Effect of Multisensory Motor Imagery Training on Muscle Performance and Coordination in Children With Spastic Diplegia
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 8 and 12 years old?
Source: NCT06676332, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cairo University
- Trial code
- NCT06676332
- Record updated
- 18 February 2025
- Original description
PURPOSE:Read full original descriptionShow less
PURPOSE:
The current study aims to:
* Determine the effect of multisensory motor imagery training on muscle performance including (peak torque, work, power) of trunk and knee flexors and extensors in children with spastic diplegia. * Determine the effect of multisensory motor imagery training on coordination, strength and agility in children with spastic diplegia.
BACKGROUND: Multisensory motor imagery training has an effect on muscle performance and coordination in children with spastic diplegia
HYPOTHESES: There will be no effect of multisensory motor imagery training on muscle performance, coordination and strength and agility in children with spastic diplegic CP.
RESEARCH QUESTION: Is there an effect of multisensory motor imagery training on coordination, strength and agility in children with spastic diplegia?
Inclusion: Their age will be ranged from 8-12 years; Mild degree of spasticity ranged from 1 to 1+ according to Modified Ashworth Scale; Their motor function will be at level I and II according to Gross Motor Function Classification System GMFCS; They will be able to follow instructions during evaluation and treatment.
Exclusion: Surgical interference in lower limbs and/or spine; - Cardiovascular or respiratory disorders; Seizures; Visual or hearing impairment; Botulinium muscular injection in the last 6 months; Muscloskeletal problems or fixed deformities in the spine and/or lower extremities.